Skip to main content
SpringerLink
Log in

Rationing of Drugs for Rare Diseases

  • Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hughes DA, Tunnage B, Yeo ST. Drugs for exceptionally rare diseases: do they deserve special status for funding? Q J Med 2005; 98: 829–836

    Article  CAS  Google Scholar 

  2. McCabe C, Claxton K, Tsuchiya A. Orphan drugs and the NHS: should we value rarity? BMJ 2005; 331: 1016–1019

    Article  PubMed  Google Scholar 

  3. McKie J, Richardson J. The rule of rescue. Soc Sci Med 2003; 56: 2407–2419

    Article  PubMed  Google Scholar 

  4. Gericke CA, Riesberg A, Busse R. Ethical issues in funding orphan drug research and development. J Med Ethics 2005; 31: 164–168

    Article  PubMed  CAS  Google Scholar 

  5. Chapman S, Reeve E, Rajaratnam G, et al. Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care. BMJ 2003; 326: 707–709

    Article  PubMed  Google Scholar 

  6. Møldrup C. No cure, no pay. BMJ 2005; 330: 1262–1264

    Article  PubMed  Google Scholar 

  7. Sudlow CL, Counsell CE. Problems with UK government’s risk sharing scheme for assessing drugs for multiple sclerosis. BMJ 2003; 326: 388–392

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this editorial.

The author has no conflicts of interest relevant to the content of this editorial.

Author information

Authors and Affiliations

  1. Centre for Economics and Policy in Health, Institute of Medical and Social Care Research, Stryd y Deon, University of Wales, Bangor, Gwynedd, LL57 1UT, Wales, UK

    Dyfrig Hughes

Authors
  1. Dyfrig Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dyfrig Hughes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, D. Rationing of Drugs for Rare Diseases. Pharmacoeconomics 24, 315–316 (2006). https://doi.org/10.2165/00019053-200624040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200624040-00001

Search

Navigation